Carisoprodol
Product Images NDC 10544-088

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 10544-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

350mg 30ct (Label Carisoprodol Tabs 350mg Bpi(10544 088 30) Rising(64980 174 10) Rev2)

This is a description of a medication called Carisoprodol Tablets, USP 350mg CIV. It comes in a package of 30 tablets, with each tablet containing 350mg of Carisoprodol USP. The medication should be kept at a controlled room temperature of 20-28°C. The package includes a lot number and an expiration date. It is important to keep the medication out of reach of children, and Calilon Federal law prohibits the transfer of the medication to someone other than the patient or person authorized by the patient. The text also mentions "spee" and "osage," but these words are not understandable and might be errors.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.